Immunotherapy & Oncology
Cancer treatment has moved from poisoning dividing cells towards directing the immune system at the tumour, and towards drugs that carry their payload only to cancerous tissue. It absorbs more drug development spending than any other area.
388 stocks
| # | Name | Holding | Trade Value |
Theme Stocks |
% of Portfolio | Status | |
|---|---|---|---|---|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
| $156B | -$2.42B | 233 | 3.42% | Reduced |
|
| 2 |
BlackRock
New York
| $141B | -$1.84B | 256 | 3.6% | Reduced |
|
| 3 |
State Street
Boston,
Massachusetts
| $82.4B | +$451M | 231 | 4.01% | Increased |
|
| 4 |
Geode Capital Management
Boston,
Massachusetts
| $35.5B | +$810M | 274 | 3.71% | Increased |
|
| 5 |
JP Morgan Chase
New York
| $32.9B | -$1.56B | 240 | 3.15% | Reduced |
|
| 6 |
Fidelity Investments
Boston,
Massachusetts
| $31.8B | -$242M | 176 | 2.44% | Reduced |
|
| 7 |
Morgan Stanley
New York
| $31.5B | +$1.13B | 275 | 2.78% | Increased |
|
| 8 |
Wellington Management Group
Boston,
Massachusetts
| $30.6B | +$765M | 64 | 5.7% | Increased |
|
| 9 |
Capital International Investors
Los Angeles,
California
| $21.8B | -$468M | 17 | 4.89% | Reduced |
|
| 10 |
Northern Trust
Chicago,
Illinois
| $19.7B | -$1B | 219 | 3.57% | Reduced |
|
| 11 |
T. Rowe Price Associates
Baltimore,
Maryland
| $19.5B | -$2.25B | 122 | 2.63% | Reduced |
|
| 12 |
Norges Bank
Oslo,
Norway
| $19.3B | +$452M | 52 | 3.37% | Increased |
|
| 13 |
Charles Schwab
San Francisco,
California
| $19.1B | +$452M | 156 | 4.84% | Increased |
|
| 14 |
Capital World Investors
Los Angeles,
California
| $19B | -$1.3B | 13 | 3.38% | Reduced |
|
| 15 |
Bank of America
Charlotte,
North Carolina
| $17.8B | -$815M | 252 | 1.79% | Reduced |
|
| 16 |
Bank of New York Mellon
New York
| $16.1B | -$364M | 165 | 3.26% | Reduced |
|
| 17 |
Capital Research Global Investors
Los Angeles,
California
| $12.8B | -$599M | 15 | 3.16% | Reduced |
|
| 18 |
Legal & General Group
London,
United Kingdom
| $12.2B | -$281M | 132 | 3.8% | Reduced |
|
| 19 |
Primecap Management
Pasadena,
California
| $11.8B | -$1.41B | 17 | 9.32% | Reduced |
|
| 20 |
Goldman Sachs
New York
| $11.4B | -$48.7M | 165 | 2.11% | Reduced |
|
| 21 |
Wells Fargo
San Francisco,
California
| $10.6B | -$289M | 256 | 2.76% | Reduced |
|
| 22 |
Dodge & Cox
San Francisco,
California
| $10.5B | -$352M | 12 | 6.69% | Reduced |
|
| 23 |
Invesco
Atlanta,
Georgia
| $10.3B | -$447M | 117 | 2.45% | Reduced |
|
| 24 |
Ameriprise
Minneapolis,
Minnesota
| $10.2B | +$388M | 87 | 3.06% | Increased |
|
| 25 |
Dimensional Fund Advisors
Austin,
Texas
| $9.84B | -$205M | 132 | 2.87% | Reduced |
|